The stock price of Mylan is soaring, but the pharmaceutical company might not be out of the woods yet. After a summer of bad headlines, Congressional testimony, and agreements to pay back millions to the government, the Pentagon is looking at how much Mylan has been overcharging since 2008.
Source: Gizmodo – EpiPen Price Hike Costs the Pentagon Millions